Dimensional Fund Advisors’s Exagen XGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-62,571
Closed -$291K – 3295
2026
Q2
$291K Hold
62,571
– – ﹤0.01% 3035
2026
Q1
$188K Buy
62,571
+36,213
+137% +$140K ﹤0.01% 3073
2025
Q4
$160K Sell
26,358
-1,029
-4% -$9.36K ﹤0.01% 3108
2025
Q3
$301K Sell
27,387
-2,835
-9% -$25.1K ﹤0.01% 3068
2025
Q2
$211K Hold
30,222
– – ﹤0.01% 3107
2025
Q1
$109K Hold
30,222
– – ﹤0.01% 3198
2024
Q4
$124K Buy
30,222
+435
+1% +$1.57K ﹤0.01% 3218
2024
Q3
$92.1K Buy
29,787
+8,748
+42% +$22.7K ﹤0.01% 3249
2024
Q2
$38.3K Sell
21,039
-5,398
-20% -$9.14K ﹤0.01% 3330
2024
Q1
$42K Sell
26,437
-9,593
-27% -$18.6K ﹤0.01% 3339
2023
Q4
$71.7K Sell
36,030
-18,369
-34% -$31.8K ﹤0.01% 3313
2023
Q3
$133K Sell
54,399
-13,462
-20% -$34.1K ﹤0.01% 3280
2023
Q2
$197K Buy
67,861
+2,604
+4% +$7.41K ﹤0.01% 3239
2023
Q1
$159K Buy
+65,257
New +$169K ﹤0.01% 3244
2022
Q3
$191K Buy
70,511
+1,698
+2% +$9.47K ﹤0.01% 3247
2022
Q2
$395K Sell
68,813
-3,238
-4% -$18.9K ﹤0.01% 3116
2022
Q1
$579K Buy
72,051
+24,038
+50% +$207K ﹤0.01% 3112
2021
Q4
$558K Buy
48,013
+14,818
+45% +$174K ﹤0.01% 3141
2021
Q3
$451K Buy
33,195
+19,035
+134% +$253K ﹤0.01% 3208
2021
Q2
$212K Buy
+14,160
New +$217K ﹤0.01% 3328

Other funds holding XGN

Dimensional Fund Advisors's XGN Position: Q3 2026 in Review

Dimensional Fund Advisors sold out of Exagen (XGN) in Q3 2026, closing a stake of 62,571 shares — an estimated $291K sold.

Dimensional Fund Advisors first reported a position in XGN in Q2 2021 and held it in 20 quarters. The position peaked at $579K in Q1 2022. 48 funds tracked by Wall St. Rank hold XGN as of Q3 2026.

  • Dimensional Fund Advisors reported no remaining Exagen position as of Q3 2026 after selling out during the quarter.
  • Dimensional Fund Advisors sold 62,571 Exagen shares in Q3 2026, an estimated $291K.
  • Dimensional Fund Advisors first reported a position in Exagen in Q2 2021 and held it in 20 quarters.
  • Dimensional Fund Advisors's Exagen position peaked at $579K in Q1 2022.
  • 48 funds tracked by Wall St. Rank held Exagen as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.